<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">Two separate investigations were conducted (Table 
 <xref rid="Tab1" ref-type="table">1</xref>). The Patient cohort included all patients, who were tested for 
 <italic>M. pneumoniae</italic> antibodies between 1 August 2017 and 31 January 2018 due to healthcare consultation and a clinically suspected 
 <italic>M. pneumoniae</italic> infection at local GPs or hospitals in the Kymenlaakso region. Two or more sera were available from 67/327 (20%) of the cases.
</p>
